Heidelberg ImmunoTherapeutics Revenue

Biotechnology Research • Heidelberg, Baden-Württemberg, Germany • 1-10 Employees

Heidelberg ImmunoTherapeutics revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Key Contact at Heidelberg ImmunoTherapeutics

Michaela Arndt

Chief Executive Officer

Company overview

Headquarters	Max-Jarecki-Str. 21, Heidelberg, 69115, DE
Website	hditx.de
NAICS	541714
Keywords	Biotechnology, Antibody Therapeutics, Oncology, Immunotherapy, Viral Diseases
Founded	2016
Employees	1-10

Heidelberg ImmunoTherapeutics Email Formats

Heidelberg ImmunoTherapeutics uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@hditx.de), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@hditx.de	100%

About Heidelberg ImmunoTherapeutics

Heidelberg ImmunoTherapeutics GmbH was founded as a spin-off from the German Cancer Research Center (DKFZ) and Heidelberg University Hospital in 2016. We are a biopharmaceutical company focusing on the clinical development of innovative, antibody-based immunotherapeutics for the treatment of viral diseases and cancer. Our lead first product, HDIT101, is being developed for the treatment of herpes simplex virus (HSV) infections, which are affecting several million people worldwide. Oral and genital herpes are the most common conditions. In some patients, herpes simplex infections lead to severe complications and even a life-threatening disease progression. A particular challenge is the treatment of herpes simplex viruses resistant to common antivirals.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Heidelberg ImmunoTherapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Heidelberg ImmunoTherapeutics has never raised funding before.

Frequently asked questions

Heidelberg ImmunoTherapeutics is located in Heidelberg, Baden-Württemberg, DE.

Heidelberg ImmunoTherapeutics generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

Heidelberg ImmunoTherapeutics has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Heidelberg ImmunoTherapeutics was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Heidelberg ImmunoTherapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Heidelberg ImmunoTherapeutics

Michaela Arndt

Chief Executive Officer

4.8

40,000 users